-+ 0.00%
-+ 0.00%
-+ 0.00%

Mereo BioPharma Group Q4 EPS $(0.01), Inline

Benzinga·03/19/2026 13:37:29
Listen to the news
Mereo BioPharma Group (NASDAQ:MREO) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is unchanged from the same period last year.